Skip to main content
. 2014 Nov 15;5(4):550–559. doi: 10.4291/wjgp.v5.i4.550

Table 1.

Antibiotic therapy in inflammatory bowel diseases

Ref. Year Antibiotics Duration Result
Crohn’s disease-primary therapy
Ursing et al[53] 1982 Metronidazole 800 mg/d 16 wk No difference from sulfasalazine
Sutherland et al[54] 1991 Metronidazole 10 or 20 mg/kg 16 wk Superior to placebo (↓ CDAI), no difference in remission
Colombel et al[55] 1999 Ciprofloxacin 500 mg 2 × d 6 wk No difference from mesalamine
Arnold et al[56] 2002 Ciprofloxacin 500 mg 2 × d 6 mo Superior to placebo (CDAI)
Prantera et al[57] 1996 Ciprofloxacin 500 mg 2 × d + metronidazole 250 mg 4 × d 12 wk No difference from prednisolone
Greenbloom et al[58] 1998 Ciprofloxacin 500 mg 2 × d + metronidazole 250 mg 3 × d 10 wk Uncontrolled, 68% remission
Leiper et al[59] 2000 Clarithromycin 250 mg 2 × d 4 wk Uncontrolled, 64% response, 48% remission
Steinhart et al[60] 2002 Ciprofloxacin 500 mg 2 × d + metronidazole 250 mg 3 × d 8 wk No improvement over budesonide alone (33% vs 38% remission)
Crohn’s disease-prevention of postsurgical relapse
Rutgeerts et al[61] 1995 Metronidazole 20 mg/kg 12 wk ↓ clinical relapse 1 yr vs placebo
Rutgeerts et al[62] 2005 Ornidazole 1 g/d 52 wk ↓ severe endoscopic relapse vs placebo
Ulcerative colitis-primary therapy
Turunen et al[63] 1999 Cipro 500 mg 2 × d 6 mo Superior to placebo
Mantzaris et al[64] 1997 Cipro 500 mg 2 × d 6 mo No benefit vs placebo
Casellas et al[65] 1998 Amoxicillin 1 g/ Clavulanic acid 250 mg 5 d ↓ mucosal IL-8 and eicosanoids vs placebo
Turner et al[66] 2014 metronidazole, amoxicillin, doxycycline (Paediatrics) Remission (46.6%)
Pouchitis
Shen et al[67] 2001 Metronidazole 20 mg/kg or Cipro 500 mg 2 × d 6 mo Both effective, Cipro > metronidazole
Gionchetti et al[68] 2000 Cipro 500 mg 2 × d and Rifaximin 1 g 2 × d 5 d 89% response, 33% remission, uncontrolled